Literature DB >> 17180231

ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme.

Angela Casini1, Guido Mastrobuoni, Claudia Temperini, Chiara Gabbiani, Simona Francese, Gloriano Moneti, Claudiu T Supuran, Andrea Scozzafava, Luigi Messori.   

Abstract

The interactions of cisplatin and its analogues, transplatin, carboplatin and oxaliplatin, with hen egg white lysozyme were analysed through ESI mass spectrometry, and the resulting metallodrug-protein adducts identified; the X-ray crystal structure of the cisplatin lysozyme derivative, solved at 1.9 A resolution, reveals selective platination of imidazole Nepsilon of His15.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17180231     DOI： 10.1039/b611122j

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  23 in total

1.  Crystallography and chemistry should always go together: a cautionary tale of protein complexes with cisplatin and carboplatin.

Authors:  Ivan Shabalin; Zbigniew Dauter; Mariusz Jaskolski; Wladek Minor; Alexander Wlodawer
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-08-28

2.  Exploring metallodrug-protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound.

Authors:  Angela Casini; Chiara Gabbiani; Elena Michelucci; Giuseppe Pieraccini; Gloriano Moneti; Paul J Dyson; Luigi Messori
Journal:  J Biol Inorg Chem       Date:  2009-03-14       Impact factor: 3.358

3.  Platinum-based drugs and proteins: reactivity and relevance to DNA adduct formation.

Authors:  Odra Pinato; Caterina Musetti; Nicholas P Farrell; Claudia Sissi
Journal:  J Inorg Biochem       Date:  2013-01-23       Impact factor: 4.155

4.  Specific derivatization of lysozyme in aqueous solution with Re(CO)3(H2O)3(+).

Authors:  Sarah L Binkley; Christopher J Ziegler; Richard S Herrick; Roger S Rowlett
Journal:  Chem Commun (Camb)       Date:  2010-01-09       Impact factor: 6.222

5.  Cisplatin binds human copper chaperone Atox1 and promotes unfolding in vitro.

Authors:  Maria E Palm; Christoph F Weise; Christina Lundin; Gunnar Wingsle; Yvonne Nygren; Erik Björn; Peter Naredi; Magnus Wolf-Watz; Pernilla Wittung-Stafshede
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

6.  Room-temperature X-ray diffraction studies of cisplatin and carboplatin binding to His15 of HEWL after prolonged chemical exposure.

Authors:  Simon W M Tanley; Antoine M M Schreurs; Loes M J Kroon-Batenburg; John R Helliwell
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-10-26

7.  Silver metallation of hen egg white lysozyme: X-ray crystal structure and NMR studies.

Authors:  Matthew J Panzner; Stephanie M Bilinovich; Wiley J Youngs; Thomas C Leeper
Journal:  Chem Commun (Camb)       Date:  2011-10-31       Impact factor: 6.222

8.  Palladium(II) and platinum(II) bind strongly to an engineered blue copper protein.

Authors:  Matthew P McLaughlin; Thomas H Darrah; Patrick L Holland
Journal:  Inorg Chem       Date:  2011-10-25       Impact factor: 5.165

9.  Direct determination of the primary binding site of cisplatin on cytochrome C by mass spectrometry.

Authors:  Ting Zhao; Fred L King
Journal:  J Am Soc Mass Spectrom       Date:  2009-02-13       Impact factor: 3.109

10.  Ruthenium anticancer drugs and proteins: a study of the interactions of the ruthenium(III) complex imidazolium trans-[tetrachloro(dimethyl sulfoxide)(imidazole)ruthenate(III)] with hen egg white lysozyme and horse heart cytochrome c.

Authors:  Angela Casini; Guido Mastrobuoni; Mattia Terenghi; Chiara Gabbiani; Enrico Monzani; Gloriano Moneti; Luigi Casella; Luigi Messori
Journal:  J Biol Inorg Chem       Date:  2007-08-07       Impact factor: 3.358
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.